Similar articles for PMID: 26310908

Year	Number of Results
1984	1
1990	1
1991	2
1995	2
1996	2
1999	3
2001	2
2004	1
2005	1
2007	1
2008	5
2009	4
2011	1
2012	6
2013	11
2014	7
2015	26
2016	16
2017	18
2018	8
2019	9
2020	10
2021	3
2022	1
2024	0

1

Strategies for combining immunotherapy with radiation for anticancer therapy.

Seyedin SN, Schoenhals JE, Lee DA, Cortez MA, Wang X, Niknam S, Tang C, Hong DS, Naing A, Sharma P, Allison JP, Chang JY, Gomez DR, Heymach JV, Komaki RU, Cooper LJ, Welsh JW. Seyedin SN, et al. Immunotherapy. 2015;7(9):967-980. doi: 10.2217/imt.15.65. Epub 2015 Aug 27. Immunotherapy. 2015. PMID: 26310908 Free PMC article. Review.

2

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M. Figueroa JA, et al. Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Int Rev Immunol. 2015. PMID: 25901860 Review.

3

Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.

Huang MA, Krishnadas DK, Lucas KG. Huang MA, et al. J Immunol Res. 2015;2015:675269. doi: 10.1155/2015/675269. Epub 2015 Oct 26. J Immunol Res. 2015. PMID: 26587548 Free PMC article. Review.

4

Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.

Baxevanis CN, Papamichail M. Baxevanis CN, et al. Cancer Immunol Immunother. 2004 Oct;53(10):893-903. doi: 10.1007/s00262-004-0523-y. Epub 2004 May 26. Cancer Immunol Immunother. 2004. PMID: 15168086 Review.

5

Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.

Michen S, Temme A. Michen S, et al. Crit Rev Immunol. 2016;36(4):329-347. doi: 10.1615/CritRevImmunol.2017019376. Crit Rev Immunol. 2016. PMID: 28322137 Review.

6

Challenges of cancer therapy with natural killer cells.

Klingemann H. Klingemann H. Cytotherapy. 2015 Mar;17(3):245-9. doi: 10.1016/j.jcyt.2014.09.007. Epub 2014 Dec 18. Cytotherapy. 2015. PMID: 25533934 Review.

7

Novel immunotherapies for hematologic malignancies.

Nelson MH, Paulos CM. Nelson MH, et al. Immunol Rev. 2015 Jan;263(1):90-105. doi: 10.1111/imr.12245. Immunol Rev. 2015. PMID: 25510273 Free PMC article. Review.

8

Update on the current revolution in cancer immunotherapy.

Renrick AN, Dunbar ZT, Shanker A. Renrick AN, et al. Immunotherapy. 2019 Jan;11(1):15-20. doi: 10.2217/imt-2018-0135. Immunotherapy. 2019. PMID: 30702010 Free article. No abstract available.

9

A new therapeutic potential for cancers: One CAR with 2 different engines!

Sheikhi A, Jafarzadeh A. Sheikhi A, et al. Hum Vaccin Immunother. 2017 Aug 3;13(8):1786-1788. doi: 10.1080/21645515.2017.1314874. Epub 2017 May 11. Hum Vaccin Immunother. 2017. PMID: 28494200 Free PMC article.

10

NK cell-based immunotherapy for cancer.

Fang F, Xiao W, Tian Z. Fang F, et al. Semin Immunol. 2017 Jun;31:37-54. doi: 10.1016/j.smim.2017.07.009. Epub 2017 Aug 31. Semin Immunol. 2017. PMID: 28838796 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year